IL6R and COVID-19: Based on this fact, drugs such as Tocilizumab, Satralizumab, and Sarilumab, as IL-6 receptor (IL-6R)-targeted monoclonal antibodies (mAbs), might prove beneficial for the treatment of COVID-19 (63).